Evidence map›Paper›PMID 25510486›Full record

ArticleLeukemia research2015

Thymineless death in F10-treated AML cells occurs via lipid raft depletion and Fas/FasL co-localization in the plasma membrane with activation of the extrinsic apoptotic pathway.

William H Gmeiner, Jamie Jennings-Gee, Christopher H Stuart, Timothy S Pardee

Open access · greenAbstract read
In one paragraph

Article in Leukemia research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

William H GmeinerDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, United States; Comprehensive Cancer Center at Wake Forest University, Wake Forest School of Medicine, Winston-Salem, NC 27157, United States; Molecular Medicine and Translational Science, Wake Forest School of Medicine, Winston-Salem, NC 27157, United States. Electronic address: bgmeiner@wakehealth.edu.
Jamie Jennings-GeeDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, United States.
Christopher H StuartMolecular Medicine and Translational Science, Wake Forest School of Medicine, Winston-Salem, NC 27157, United States.
Timothy S PardeeDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, United States; Comprehensive Cancer Center at Wake Forest University, Wake Forest School of Medicine, Winston-Salem, NC 27157, United States; Department of Hematology/Oncology, Wake Forest School of Medicine, Winston-Salem, NC 27157, United States.
Wake Forest University · US

Funding

Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
DNA-DIRECTED EFFECTS OF FdUMP(N)U01CA102532 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI GMEINER, WILLIAM H. · 2005 to 2009
$1.6M
Metabolic contribution to cell viability and therapy resistance in the acuteK08CA169809 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI PARDEE, TIMOTHY SEBASTIAN · 2012 to 2016
$840k
NCI NIH HHS K08 CA169809NCI NIH HHS P30 CA012197NCI NIH HHS U01 CA102532NCI NIH HHS U01CA102532
6 · The paper itself

Abstract

The polymeric fluoropyrimidine F10 displays excellent anti-leukemia activity in pre-clinical models of acute myelogenous leukemia (AML) through dual targeting of thymidylate synthase and DNA topoisomerase 1. Here we report that F10 activates the extrinsic apoptotic pathway in AML cells by enhancing localization of Fas and Fas ligand (FasL) at the plasma membrane and while reducing overall lipid raft levels promotes Fas/FasL co-localization in remaining lipid rafts. The HMG-CoA synthase inhibitor simvastatin was synergistic with F10 and induced cell death via similar apoptotic processes. Our results are consistent with diverse processes activating a common apoptotic pathway characterized by reduced overall levels of lipid rafts and Fas/FasL co-localization in the plasma membrane, including in remaining lipid rafts which may play a role in both cell-survival and cell death signaling.

Indexed as

Antineoplastic AgentsApoptosisFas Ligand Proteinfas ReceptorHL-60 CellsHumansLeukemia, Myeloid, AcuteMembrane MicrodomainsNeoplasm ProteinsPyrimidinesAntineoplastic AgentsFASLG protein, humanFas Ligand ProteinFAS protein, humanfas ReceptorNeoplasm ProteinsPyrimidinesApoptosisDNAF10FasLipid rafts

Identifiers

PMID25510486
PMCPMC4306618
OpenAlexW2067494343

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.